BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its second quarter ended June 30, 2025. Selected Financial Information: Variance Variance Q2 2025 vs Q2 2025 vs Dollars are in thousands, except per share amounts Q2 2025 Q2 2024 Q1 2025 Revenue $ 274,072 (19 )% (7 )% Gross profit margin* 20.4 % (40 )bps 40 bps Net loss attributable to common stockholders $ (6,659 ) (59 )% (1,259 )% Diluted
Related Questions
Are there any operational or strategic initiatives underway to reverse the negative revenue trend?
How does the continued net loss impact the company's balance sheet and future capital raising needs?
What macro‑economic factors, such as labor shortages or reimbursement rates, could influence the company's performance in upcoming quarters?
What recent contract wins or losses might explain the observed revenue dip?
Will the negative sentiment score of -70 likely amplify short‑term price volatility?
How does Cross Country Healthcare's Q2 2025 performance compare to its competitors in the healthcare staffing sector?
What factors contributed to the 40 basis‑point improvement in gross profit margin despite lower revenue?
What guidance or outlook does management provide for the remainder of 2025 and beyond?
How will the 19% decline in Q2 2025 revenue affect the company's cash flow and operating runway?
Is the widening net loss attributable to common stockholders a sign of deteriorating profitability or a one‑time charge?